Search Results

CVS CVS Health Corporation - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
CVS Stock | Fundamental Analysis & Investment Insights
NYSE Healthcare Healthcare Plans
Current Price Live
$78.6
Analyst Target
$94.96
+20.8% Upside
52W High
$85.15
52W Low
$52.21

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
78%
Analysis Accuracy
CVS exhibits weak financial health with a Piotroski F-Score of 4/9, indicating marginal stability, and lacks an Altman Z-Score, raising concerns about financial distress risk. Despite a strong revenue growth of 7.8% and a bullish analyst recommendation, the company suffers from abnormally low profitability metrics, including a near-zero profit margin (0.12%) and an extremely high P/E ratio (206.84), suggesting severe earnings deterioration. The dividend is dangerously overpaid with a 700% payout ratio, and insider selling adds to negative sentiment. While the stock trades below the analyst target price of $94.96, fundamental weaknesses and deteriorating earnings trends outweigh valuation optimism.

Key Strengths

Revenue growth of 7.8% YoY outpaces sector average in a stable industry
Analyst consensus supports a 'buy' rating with a $94.96 target price
Dividend yield of 3.27% remains attractive relative to sector
Enterprise-scale presence in healthcare with $99.78B market cap
Price/Sales ratio of 0.25 suggests potential revenue-based undervaluation

Key Risks

Piotroski F-Score of 4 indicates weak financial health and operational instability
Extremely high P/E ratio of 206.84 signals severe earnings collapse or accounting anomalies
Profit margin of 0.12% and ROE of 0.58% reflect poor capital efficiency
Dividend payout ratio of 700% is unsustainable and threatens future distributions
Insider selling activity indicates lack of confidence from corporate insiders
AI Fair Value Estimate
Based on comprehensive analysis
$22.16
-71.8% below current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare CVS against industry averages and similar companies

Unlock Sector Insights

See how CVS compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning CVS from our newsroom.

Newest → oldest

See the full CVS analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile